Silence Therapeutics SLN
NASDAQ SLN
$19.77 -0.02 (-0.08%)
As of: Nov 11, 2026 · 3:10 PM EST

Silence Therapeutics (SLN) Cash & Equivalents (2018 - 2026)

Updated

Silence Therapeutics (SLN) reported Cash & Equivalents of $72.05 million for the quarter ended Jun 30, 2026, up 72.6% from $41.74 million a year earlier.

Analysis

Silence Therapeutics (SLN) Cash & Equivalents (2018 - 2026) Analysis & Trends

As of Dec 31, 2025, Silence Therapeutics posted Cash & Equivalents of $11.28 million, down 90.7% from the prior year.

  • Cash & Equivalents has a five-year compound annual growth rate of -20.4% (years ended Dec 2020 to Dec 2025).
  • By year, Cash & Equivalents came in at $121.33 million in the year ended Dec 31, 2024 (+76.4%), $68.79 million in the year ended Dec 31, 2023 (+1.4%), $67.84 million in the year ended Dec 31, 2022 (-32.9%) and $101.18 million in the year ended Dec 31, 2021 (+187.0%).
  • Five-year quarterly Cash & Equivalents spans a low of $5.66 million in the quarter ended Mar 31, 2026 and a high of $121.33 million in the quarter ended Dec 31, 2024.
  • Year over year, Cash & Equivalents gained in two of the last four quarters, with an average decline of 7.1%.
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $5.66 million (quarter ended Mar 31, 2026), $11.28 million (quarter ended Dec 31, 2025) and $82.03 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 Silence Therapeutics 935.01 Mn 862.91 Mn - 72.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 72.05 Mn
Mar 31, 2026 5.66 Mn
Dec 31, 2025 11.28 Mn
Sep 30, 2025 82.03 Mn
Jun 30, 2025 41.74 Mn
Mar 31, 2025 64.89 Mn
Dec 31, 2024 121.33 Mn
Sep 30, 2024 82.91 Mn
Jun 30, 2024 138.45 Mn
Mar 31, 2024 142.75 Mn
Dec 31, 2023 68.80 Mn
Sep 30, 2023 71.78 Mn
Jun 30, 2023 37.49 Mn
Mar 31, 2023 57.89 Mn
Dec 31, 2022 66.09 Mn
Sep 30, 2022 100.54 Mn
Jun 30, 2022 62.56 Mn
Mar 31, 2022 77.91 Mn
Dec 31, 2021 99.26 Mn
Sep 30, 2021 95.96 Mn
API Access

Silence Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SLN&period=max&api_key=YOUR_API_KEY